Review of the size effect in investing (AQR)

Below is a link to an article on investing in small cap stocks.  The paper dispels the long held belief that small stocks outperform large cap stocks.  The paper revisits and corrects prior studies that led investors to champion small cap stocks.  These prior studies were distorted by pricing errors in the CRSP pricing database when a stock was delisted.

AQR – Size effect

The study concludes that the small cap effect is weak at best and mostly explained away by higher beta and the value effect.  I know several firms that drink the small-cap Kool-Aid.  Should a client show concern at Crestwood’s modest allocation to small caps, this paper will support the construction of our models.

Thanks,

John

 

 

Medtronic MDT reported strong 4Q FY18 results and a conservative initial FY19 guidance

Thesis intact. Key takeaways from the quarter:

Medtronic reported strong 4Q FY18 sales and earnings results this morning with +6.5% organic sales growth and +6.5% EPS growth. Top line growth was robust across all segments, with Diabetes impressive at +21% (thanks to US patient demand for its insulin pump). Operating margin expanded (+80bps) in the quarter, thanks to cost savings initiatives.

The initial FY19 organic sales growth guidance of +4-4.5% is achievable and leaves room for upside, while operating margin should expand by 50bps (better than FY18 +20bps) and EPS growth in the +8-9% range. Management thinks that its emerging market business will grow in the low double digits going forward, following a +15.5% growth in 4Q. Free cash flow conversion will improve going forward, as litigation and tax payments diminish. The tax reform will push for more overseas assets liquidation to continue.

In an interesting move, MDT hired Michael Weinstein earlier this month, a well-regarded sell-side analyst (JP Morgan), to lead its strategy. He’s bringing a deep knowledge of the medtech space, and we can expect some M&A/divestiture/capital allocation moves in the coming year. The next catalyst will be when the company introduces its long-term outlook during its investor day on June 5th.

Valuation unchanged, we are maintaining our $93 price target, reflecting the recent strength in the business.

Continue reading “Medtronic MDT reported strong 4Q FY18 results and a conservative initial FY19 guidance”

TJX 1Q19 Earnings Update

TJX beat on revenue and EPS with better than expected SSS. Performance was solid across divisions and concerns around inventory availability were dispelled. SSS were +3% vs guidance of +1-2% with strong performance across their apparel and home categories. Traffic was the primary driver across all 4 divisions. Marmaxx division (60% of revenue) SSS were +4% driven mostly by traffic and slightly by ticket. International SSS were +1% despite a “challenging retail environment” in Europe (where they have over 500 stores). Full year guidance is 1-2% SSS (in their 40+ yr. history they’ve had only 1 year of negative SSS). They also mentioned they “have been disproportionately attracting new millennial and Gen Z customers.” Merchandise margins compressed a little, but gross margins were flat. They are seeing some headwinds from wages and “significantly higher” freight costs, offset by positive Fx and a lower tax rate. The midpoint of full year guidance was raised despite these headwinds and with a lower expected tax benefit. Full year EPS should be about $4.07 plus a $0.72 benefit from a lower tax rate.

Continue reading “TJX 1Q19 Earnings Update”

Cisco 3Q18 Earnings Update

Thesis intact, key takeaways:

Cisco reported Q3 earnings and beat on the top and bottom line and guided in line with street. While the quarter was strong, the growth of Services revenue (26% of revs) seemed to be a little lower than expected and gross margins were lower. They had 70 bps of gross margin compression driven almost entirely by higher memory costs. This is similar to previous quarters and is an industry wide phenomenon. They continue to make good progress on their transformation from a hardware business to a software and services focused business. The percentage of recurring revenue is now at 32% – they set a goal of 37% by 2020. Enterprise saw accelerated growth at +11% YoY driven by strong growth with Catalyst 9k units –the 9k switches are only sold with a subscription and are a key part their strategy of shifting their core business to recurring revenue. They saw strength in both campus and data center switching. Additionally, Applications and Security were both strong – up +19% and 11% respectively. As expected, Service Provider revenue trends continue to be weak, pressuring router sales – though exposure to this end market is decreasing. They repurchased $6.2bn worth of shares in Q3 and still have $25B remaining in their buyback authorization which they aim to complete in 1.5-2yrs.

Valuation:

· They have 3% dividend yield which is easily covered by their FCF.

· FCF yield of over 6.5% is well above sector average and is supported by an increasingly stable recurring revenue business model and rising FCF margins.

· The company trades on hardware multiple, but the multiple should expand as they keep evolving to a software, recurring revenue model. Hardware trades on a lower multiple because it is lower margin, more cyclical and more capital intensive.

Thesis on Cisco

· Industry leader in strong secular growth markets: video usage, virtualization and internet traffic.

· Significant net cash position and strong cash generation provide substantial resources for CSCO to develop and/or acquire new technology in high-growth markets and also return capital to shareholders.

· Cisco has taken significant steps to restructure the business which has helped reaccelerate growth and stabilize margins.

$CSCO.US

[tag CSCO]

Sarah Kanwal

Equity Analyst, Director

Direct: 617.226.0022

Fax: 617.523.8118

Crestwood Advisors

One Liberty Square, Suite 500

Boston, MA 02109

www.crestwoodadvisors.com

PLEASE NOTE!

We moved! Please note our new location above!

TORIX – Q1 2018 Commentary

TORIX – Q1 2018 Commentary

During the quarter, Tortoise MLP & Pipeline Fund underperformed its benchmark. The MLP and broad energy sectors sold off during the quarter due to negative sentiment as well as uncertainty following a FERC ruling. The team remains optimistic about the space believing that commodity prices will remain stable and that companies are better positioned to self-fund capital projects. As of the end of last month, the TTM yield of TORIX is 3.09%.

Continue reading “TORIX – Q1 2018 Commentary”

Quick Update On Earnings So Far…

So far ~80% of the companies in the S&P 500 have reported earnings.

78% have beat on EPS. The 5-year average is 70%.

77% have beat on sales which is a record.

55% of companies have issued negative guidance which is well below the 5 yr average.

For EPS beats: consumer discretionary, tech and Energy have had the highest % surprise.

For revenue beats: REITs, Industrials and utilities have had the highest % surprise.

According to FactSet, the market is rewarding upside earnings surprises less than average and punishing downside earnings surprises more than average.

For all of 2018, analysts are projecting earnings growth of 19.5% and revenue growth of 7.2%.

Forward P/E Ratio is 16x – it was 16.4x at the beginning of the year. The 5-year average is 16.1x and the 10-Year average is 14.3x.

Continue reading “Quick Update On Earnings So Far…”

Booking Holdings 1Q Earnings Update

Current Price: $2,045 Price Target: $2,400

Position Size: 3% TTM Performance: 20%

Bookings reported a better top and bottom line but guidance disappointed. Total bookings for the quarter increased 21% to $25B (+12% constant currency). The source of the disappointing 2Q guidance is expectations of decelerating room night growth (+7-11% vs +13% in 1Q) caused by a reduction in performance advertising spend. Performance ad spending is primarily with Google and to a lesser extent with sites like TripAdvisor and Trivago. They are making a deliberate trade-off in reducing costlier (and fading ROI) performance ad spend, despite the impact to room night growth. The benefit is hitting margins and was the cause of the big EPS beat. This strategy is not new – rising advertising costs have been a theme across the industry and their response is consistent with what they have said the last couple quarters and is not a surprise. They are shifting ad dollars to brand advertising (like TV) in an attempt to get more direct traffic to their site as the ROI on performance advertising has gone down and as a result direct traffic is increasing as a % of the mix. After last quarter, many speculated that this may disrupt room night growth – which it has. The long-term thesis, however, is intact and they still have plenty of runway for growth.

Continue reading “Booking Holdings 1Q Earnings Update”

Aramark 2Q18 Earnings Update

Aramark reported 2Q18 earnings, beating on the top and bottom line and raising the midpoint of EPS guidance. Revenue was up 6% constant currency with about 2% organic growth. The quarter included partial results from AmeriPride and a full quarter of Avendra. The key positive was the improvement in adjusted operating margins in conjunction with top line growth as the two together have been elusive. Importantly, the margin expansion was led by their core US food service business in contrast to their competitor Sodexo’s profit warning on inflation and increased competition. Sentiment was bad heading into the quarter as Aramark has had trouble hitting their organic growth and margin targets. In 2017, they disappointed with organic growth, but saw margin expansion. Then last quarter they saw meaningfully improved top line growth at the expense of 50bps in margin contraction. This was largely blamed on the onboarding of new contract wins. Management says they are on track to hit the FY18 7.2% margin target that they set in 2015, though with much of it back half weighted (implies a 7.9% adj. op. margin in 2H18 vs 6.5% in 1H18). Legacy growth was slightly below long-term target for 1Q, but they said they expect the legacy business to hit their “at least 3%” target for the full year. For 1H18 they are at 3.4%. Without adjustments, their operating profit would have been down almost 30%. Some of their adjustments and the capitalization of certain client related costs are a source of skepticism around the validity of their margins. This margin concern has been reinforced by profit issues at Sodexo and talk of rising delivery costs from their primary distributor, Sysco. Specifically, client contract incentives represent cash payments for renovations of client facilities – this hits the capex line and is in “other assets” on the balance sheet (net of accumulated amortization it’s close to $1B). Adj. operating income adds back that depreciation and, in doing so, added 80bps to the 2Q adj. operating margin. Longer term, their acquisitions will help with margins through increased purchasing scale with Avendra and better capacity utilization and route density with AmeriPride.

Continue reading “Aramark 2Q18 Earnings Update”

Crestwood’s ESG initiative

On 5/8/18, Crestwood unveiled its ESG integration initiative.  For individual stocks, ESG ratings will help inform our evaluation of management.  To derive ESG rankings, we have combined the services of RepRisk (news-based) with Sustainalytics (disclosure-based).  We believe this process will help reduce risk, improve performance and help differentiate Crestwood’s investments.  Please see below presentation:

ESG presentation

Thanks to the Research Team for all their work!

John